Fluvoxamine


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000647 Amnesia PMID:11778459; PMID:17026779
MESH:D001068 Feeding and Eating Disorders PMID:11439417
MESH:D001247 Asthenia PMID:9164424
MESH:D001480 Basal Ganglia Diseases PMID:1583525
MESH:D001919 Bradycardia PMID:7804678
MESH:D001927 Brain Diseases PMID:1429480
MESH:D002653 Child Behavior Disorders PMID:19364290
MESH:D003128 Coma PMID:3136836
MESH:D003221 Confusion PMID:1527234
MESH:D003866 Depressive Disorder PMID:8256637
MESH:D003875 Drug Eruptions PMID:17644482
MESH:D004401 Dysarthria PMID:10200869
MESH:D004415 Dyspepsia PMID:9164424; PMID:9171912
MESH:D004421 Dystonia PMID:10200869
MESH:D004775 Enuresis PMID:20119596
MESH:D004827 Epilepsy PMID:1958958
MESH:D005076 Exanthema PMID:17644482
MESH:D005221 Fatigue PMID:8698682
MESH:D005767 Gastrointestinal Diseases PMID:1600911; PMID:8923094
MESH:D005879 Tourette Syndrome PMID:7952995
MESH:D006212 Hallucinations PMID:12923827; PMID:17026779
MESH:D006261 Headache PMID:9164424
MESH:D006530 Hepatorenal Syndrome PMID:15930079
MESH:D006948 Hyperkinesis PMID:12604093; PMID:2576810
MESH:D006970 Disorders of Excessive Somnolence PMID:15902588; PMID:9164424; PMID:9864083
MESH:D007010 Hyponatremia PMID:11195401; PMID:12086550; PMID:8804257
MESH:D007024 Hypotension, Orthostatic PMID:1583525
MESH:D007172 Erectile Dysfunction PMID:9805292
MESH:D007174 Disruptive, Impulse Control, and Conduct Disorders PMID:12680750
MESH:D007177 Inappropriate ADH Syndrome PMID:11195401; PMID:12086550; PMID:8334062
MESH:D007319 Sleep Initiation and Maintenance Disorders PMID:10954064; PMID:8698682; PMID:9164424
MESH:D008107 Liver Diseases PMID:15349014
MESH:D008133 Long QT Syndrome PMID:25560394
MESH:D008538 Meige Syndrome PMID:18081639
MESH:D009127 Muscle Rigidity PMID:9864083
MESH:D009207 Myoclonus PMID:19050415; PMID:8530337
MESH:D009325 Nausea PMID:8698682; PMID:8835705; PMID:8986013; PMID:9164424
MESH:D009459 Neuroleptic Malignant Syndrome PMID:15800166
MESH:D011618 Psychotic Disorders PMID:12923827
MESH:D012640 Seizures PMID:15349014; PMID:15763129; PMID:7568372; PMID:8473723
MESH:D012893 Sleep Wake Disorders PMID:2107954
MESH:D013262 Stevens-Johnson Syndrome PMID:25811541
MESH:D013375 Substance Withdrawal Syndrome PMID:8486592; PMID:8889907
MESH:D013981 Tic Disorders PMID:10434483
MESH:D014202 Tremor PMID:19050415; PMID:8986013; PMID:9864083
MESH:D014987 Xerostomia PMID:8698682; PMID:9164424
MESH:D017109 Akathisia, Drug-Induced PMID:1906498; PMID:24568368; PMID:7673653; PMID:9864083
MESH:D019958 Attention Deficit and Disruptive Behavior Disorders PMID:11765279
MESH:D020018 Sexual Dysfunctions, Psychological PMID:10192595; PMID:7949503; PMID:8665544; PMID:8831451; PMID:9054202; PMID:9292833
MESH:D020230 Serotonin Syndrome PMID:12456895; PMID:8127934
MESH:D053206 Nocturnal Enuresis PMID:17630870
MESH:D053840 Brugada Syndrome PMID:19875396
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:15930079

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.